NASDAQ: TRML
Tourmaline Bio Inc Stock Ownership - Who owns Tourmaline Bio?

Insider buying vs selling

Have Tourmaline Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sandeep Chidambar KulkarniCEO2024-08-211,779$14.85
$26.42kBuy
Sandeep Chidambar KulkarniCEO2024-08-165,221$13.79
$72.00kBuy

1 of 1

TRML insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TRML insiders and whales buy or sell their stock.

TRML Shareholders

What type of owners hold Tourmaline Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Suzanne Ildstad21.90%5,625,597$94.79MInsider
Longitude Capital Partners III LLC12.54%3,220,775$54.27MInsider
Sandip Agarwala12.54%3,220,775$54.27MInsider
Ra Capital Management LP9.88%2,538,925$42.78MInstitution
Avoro Capital Advisors LLC8.65%2,222,222$37.44MInstitution
Blackrock Inc7.02%1,803,900$30.40MInstitution
Tcg Crossover Management LLC5.75%1,477,593$24.90MInstitution
Pfizer Inc4.95%1,272,214$21.44MInstitution
Vanguard Group Inc4.31%1,106,125$18.64MInstitution
Blue Owl Capital Holdings LP4.20%1,079,321$18.19MInstitution

1 of 3

TRML vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRML56.98%43.02%Net Buying
OMER45.74%6.73%
CELC80.30%12.35%Net Buying
DNA9.80%90.20%Net SellingNet Selling
ERAS72.86%27.14%Net Buying

Tourmaline Bio Stock Ownership FAQ

Who owns Tourmaline Bio?

Tourmaline Bio (NASDAQ: TRML) is owned by 89.01% institutional shareholders, 67.20% Tourmaline Bio insiders, and 0.00% retail investors. Suzanne Ildstad is the largest individual Tourmaline Bio shareholder, owning 5.63M shares representing 21.90% of the company. Suzanne Ildstad's Tourmaline Bio shares are currently valued at $91.44M.

If you're new to stock investing, here's how to buy Tourmaline Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.